000

ANTEROGEN

No trades
See on Supercharts
Market capitalization
‪138.57 B‬KRW
‪−2.84 B‬KRW
‪6.50 B‬KRW
‪7.56 M‬
Beta (1Y)
0.96

About ANTEROGEN

Headquarters
Seoul
Employees (FY)
37
Founded
2000
ISIN
KR7065660003
FIGI
BBG00BDRGMN0
Anterogen Co., Ltd. engages in the development and sale of stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell, and stem cell conditioned media. It also offers stem cell banking and analysis services. The company was founded on March 16, 2000 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 065660 is 14250 KRW — it has decreased by 1.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ANTEROGEN stocks are traded under the ticker 065660.
065660 stock is 2.67% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is ANTEROGEN there?
Yes, you can track ANTEROGEN financials in yearly and quarterly reports right on TradingView.
065660 stock has fallen by 2.93% compared to the previous week, the month change is a 1.79% fall, over the last year ANTEROGEN has showed a 30.99% decrease.
065660 net income for the last quarter is ‪−190.64 M‬ KRW, while the quarter before that showed ‪−1.03 B‬ KRW of net income which accounts for 81.56% change. Track more ANTEROGEN financial stats to get the full picture.
Today ANTEROGEN has the market capitalization of ‪138.58 B‬, it has increased by 3.49% over the last week.
No, 065660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 065660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANTEROGEN stock right from TradingView charts — choose your broker and connect to your account.
065660 reached its all-time high on Apr 16, 2018 with the price of 238000 KRW, and its all-time low was 12300 KRW and was reached on Oct 18, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 37.00 employees. See our rating of the largest employees — is ANTEROGEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANTEROGEN technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANTEROGEN stock shows the sell signal. See more of ANTEROGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANTEROGEN EBITDA is ‪−4.23 B‬ KRW, and current EBITDA margin is −65.02%. See more stats in ANTEROGEN financial statements.